NatureCell Co.Ltd
NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of… Read more
NatureCell Co.Ltd - Asset Resilience Ratio
NatureCell Co.Ltd (007390) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how NatureCell Co.Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down NatureCell Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩-60.00 | -0.0% |
| Total Liquid Assets | ₩-60.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: NatureCell Co.Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
NatureCell Co.Ltd Industry Peers by Asset Resilience Ratio
Compare NatureCell Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AGP Ltd
KAR:AGP |
Pharmaceuticals | 0.71% |
|
Euro-Med Laboratories Phils Inc
PSE:EURO |
Pharmaceuticals | 1.89% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620 |
Pharmaceuticals | 4.28% |
|
Sam-A Pharm. Co. Ltd
KQ:009300 |
Pharmaceuticals | 34.37% |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040 |
Pharmaceuticals | 5.22% |
|
WooGene B&G Co. Ltd
KQ:018620 |
Pharmaceuticals | 3.35% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
Annual Asset Resilience Ratio for NatureCell Co.Ltd (2009–2024)
The table below shows the annual Asset Resilience Ratio data for NatureCell Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 39.40% | ₩28.37 Billion | ₩72.00 Billion | -4.27pp |
| 2023-12-31 | 43.67% | ₩29.87 Billion | ₩68.40 Billion | +10.43pp |
| 2022-12-31 | 33.24% | ₩31.26 Billion | ₩94.02 Billion | -13.49pp |
| 2021-12-31 | 46.73% | ₩32.55 Billion | ₩69.65 Billion | -9.82pp |
| 2020-12-31 | 56.56% | ₩48.50 Billion | ₩85.75 Billion | +6.86pp |
| 2019-12-31 | 49.70% | ₩46.28 Billion | ₩93.11 Billion | +21.58pp |
| 2018-12-31 | 28.12% | ₩14.87 Billion | ₩52.88 Billion | +9.95pp |
| 2017-12-31 | 18.16% | ₩9.34 Billion | ₩51.44 Billion | +11.61pp |
| 2016-12-31 | 6.55% | ₩3.45 Billion | ₩52.67 Billion | +6.43pp |
| 2015-12-31 | 0.12% | ₩57.04 Million | ₩45.97 Billion | -0.29pp |
| 2014-12-31 | 0.41% | ₩100.40 Million | ₩24.54 Billion | -5.70pp |
| 2010-12-31 | 6.11% | ₩1.39 Billion | ₩22.70 Billion | -10.08pp |
| 2009-12-31 | 16.18% | ₩4.63 Billion | ₩28.58 Billion | -- |